Significant Ownership of Bleichroeder LP
- Large-stake filing summary
-
- Recent SEC Schedule 13D/G filings for Bleichroeder LP focus on large-stake beneficial ownership disclosures and amendments.
- Use this view to spot new large holders, amended positions, and activist-style ownership evidence.
- Manager signature
- Andrew Gundlach - Chairman and CEO
- Manager location
- New York, NY
Large-stake snapshot
1 signal
Manager
Names, identifiers, and filing context for this profile.
2 identity fields
Follow Filing Activity
Follow Bleichroeder LP with Pro and return when a new Schedule 13D/G filing changes the record on this page.
Pro alert delivery is coming soon and remains tied to source-backed filing changes rather than inferred market advice.
CIK context first
Continue from Bleichroeder LP
Significant Ownership of Bleichroeder LP
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| First Eagle Real Estate Debt Fund | Class I Common Shares of Beneficial Interest, $0.001 par value | 41% | 1,249,142 | -8.7% | Bleichroeder LP | 07 Jul 2026 | |||
| LIQT | LiqTech International, Inc. | Common Stock, $0.001 par value | 34% | $1,304,718 | 3,182,239 | 0% | Bleichroeder LP | 26 Mar 2025 | |
| MDXH | MDxHealth SA | Ordinary Shares | 33% | 31,648,563 | +326% | Bleichroeder LP | 11 Aug 2026 | ||
| SCND | Scientific Industries, Inc. | Common Stock, $0.05 par value | 21% | $2,009,119 | -$185,000 | 2,715,026 | -8.4% | Bleichroeder LP | 30 Sep 2025 |
| LIQT | LiqTech International, Inc. | Common Stock, $0.001 par value | 21% | $15,072,103 | +$8,103,000 | 6,882,239 | +116% | Bleichroeder LP | 05 Jun 2026 |
| INVE | Identiv, Inc. (INVE) | Common Stock, $0.001 par value | 20% | $19,992,849 | +$639,143 | 5,247,467 | +3.3% | Bleichroeder LP | 24 Jun 2026 |
| IVAC | Intevac, Inc. | Common Shares | 19% | $20,130,897 | 5,039,023 | Bleichroeder LP | 19 Mar 2025 | ||
| DUOT | Duos Technologies Group, Inc. | Common Shares | 18% | $62,843,235 | +$48,832,300 | 6,750,079 | +349% | Bleichroeder LP | 30 Jun 2026 |
| IDN | Intellicheck, Inc. | Common Shares | 11% | $5,391,316 | 2,073,583 | Bleichroeder LP | 19 Mar 2025 | ||
| CUE | Cue Biopharma, Inc. | Common Stock, par value $0.001 per share | 10% | $5,269,789 | 6,127,662 | 0% | Bleichroeder LP | 19 Mar 2025 | |
| BRFH | Barfresh Food Group Inc. | Common Shares | 10% | $4,670,617 | +$693,050 | 1,633,083 | +17% | Bleichroeder LP | 31 Mar 2026 |
| CLRB | Cellectar Biosciences, Inc. | Common Shares | 10% | $2,125,829 | +$1,599,829 | 808,300 | +304% | Bleichroeder LP | 30 Jun 2026 |
| SINT | SINTX TECHNOLOGIES INC | Common Shares | 10% | $1,100,772 | 647,513 | Bleichroeder LP | 30 Jun 2026 | ||
| COCHW | ENVOY MEDICAL, INC. | Class A Common Shares | 10% | $520,510 | 7,839,000 | Bleichroeder LP | 31 Mar 2026 | ||
| EVOK | Evoke Pharma, Inc. | Common Shares | 10% | $63,223 | 158,058 | -81% | Bleichroeder LP | 24 Mar 2025 | |
| CRIS | Curis Inc | Common Shares | 9.9% | $1,636,346 | 1,035,662 | Bleichroeder LP | 31 Mar 2025 | ||
| FLNT | Fluent, Inc. | Common Shares | 8.2% | $10,362,855 | -$1,151,427 | 2,571,428 | -10% | Bleichroeder LP | 30 Jun 2026 |
| DTIL | PRECISION BIOSCIENCES INC | Common Shares | 8.2% | $7,809,000 | +$3,390,750 | 1,900,000 | +77% | Bleichroeder LP | 31 Dec 2025 |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES ORD | Common Shares | 8% | $2,800,000 | 4,000,000 | Bleichroeder LP | 30 Jun 2025 | ||
| ERNA | ERNEXA THERAPEUTICS INC. | Common Shares | 6.9% | $14,400 | 80,000 | Bleichroeder LP | 31 Mar 2026 | ||
| GUER | Guerrilla RF, Inc. | Common Shares | 6.5% | $1,986,799 | -$237,201 | 714,676 | -11% | Bleichroeder LP | 30 Jun 2026 |
| MODD | Modular Medical, Inc | Common Shares | 6.2% | $1,516,437 | 336,986 | Bleichroeder LP | 30 Jun 2026 | ||
| CMPO | CompoSecure, Inc. | Class A Common Stock, $0.0001 par value per share | 4.7% | $43,808,462 | 3,897,550 | Bleichroeder LP | 30 Sep 2024 | ||
| SMTK | SmartKem, Inc. | Common Shares | 4.1% | $389,199 | 231,666 | 0% | Bleichroeder LP | 30 Sep 2025 | |
| APTO | Aptose Biosciences Inc. | Common Shares | 1.6% | $4,583 | -$13,350 | 41,666 | -74% | Bleichroeder LP | 30 Jun 2025 |
Schedules 13D/G Reported by Bleichroeder LP:
| Sym | Target | Class | Ownership | Change | Current shares | Change | Value | Reporting name | Form | Report period | Filing date |
|---|
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.